Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome

Abstract

No funding and no competing interests.

Predictive Value of Live Birth Rate Based on Different Intrauterine Adhesion Evaluation Systems Following

“…It is di cult to compare live birth rates with other studies due to the different durations of follow-up, variable proportions of different severities, different post-surgery treatments and retrospective bias. One study reported that the live birth rate after hysteroscopic treatment was 63.7% (79/124) with 14-year follow-up [35], whereas the live birth rate in our series was 53.1% (68 /128), which may be in part due to the shorter duration of follow-up. Another study from one hospital in China, with the similar inclusion criteria and management of IUA to our study, reported a similar live birth rate of 42.2% (140/332) as in our study after following up for 27±9 months [36].…”

Prevention of postoperative adhesion reformation by intermittent intrauterine balloon therapy: a randomised controlled trial

“…freeze-dried amnion grafts) would produce additional benefit. In our study we have followed up our patients for at least 1 year, similar to a recently published cohort study from the Sydney group 33 ; however, future studies could follow up the reproductive outcome of patients including live birth and obstetric complications for up to 2 years, as the more than 68% majority will be expected to have conceived by then. 34 In addition, purpose-designed balloon catheters with a shape more compatible with the uterine cavity could be considered as a refinement, as they may prove to be less painful for the patient and more effective in terms of reaching the more distal areas of the uterine cavity, such as the tubal ostia and lower part of the uterus.…”

Aspirin inhibits endometrial fibrosis by suppressing the�TGF‑β1‑Smad2/Smad3 pathway in intrauterine adhesions

“…The appropriate dose of aspirin required for endometrial repair following TcRA recovery requires a continuous follow-up study. In addition, obstetric complications should be observed, including placentation issues, prematurity and postpartum hysterectomy following treatment for IUAs (47). For example, intrauterine adhesions may lead to placenta accreta and the risk of severe postpartum haemorrhage (48).…”